Marijuana Internacional

"Following treatment, two-thirds of the cohort exhibited a greater than 50 percent reduction in seizure frequency, with 26 percent of participants experiencing a greater than 75 percent reduction. Many of the patients caregivers also observed positive changes beyond seizure control, including better attention, improved sleep, and enhanced motor function. Side effects related to CBD treatment were mild."
.
 
Werbung:
"Rates of suicide in Canada remained stable following the adoption of adult-use cannabis legalization, according to data published in the journal BJPsych Open.
.

Canadian investigators assessed the number of hospitalizations related to suicide during the six months immediately following legalization and again, two years later. Suicide rates remained stable during the study period. Researchers also acknowledged, “Individuals present to the emergency department with cannabis use less frequently than alcohol.”
.
The study’s authors concluded: “Post-
cannabis legalization, there is not an ongoing increase in emergency department presentations for suicidal ideation and attempts. This is in line with other work in Canadian jurisdictions showing no increases in cannabis-related emergency department presentations overall post-legalization.”
.
 
"Rates of suicide in Canada remained stable following the adoption of adult-use cannabis legalization, according to data published in the journal BJPsych Open.
.

Canadian investigators assessed the number of hospitalizations related to suicide during the six months immediately following legalization and again, two years later. Suicide rates remained stable during the study period. Researchers also acknowledged, “Individuals present to the emergency department with cannabis use less frequently than alcohol.”
.
The study’s authors concluded: “Post-
cannabis legalization, there is not an ongoing increase in emergency department presentations for suicidal ideation and attempts. This is in line with other work in Canadian jurisdictions showing no increases in cannabis-related emergency department presentations overall post-legalization.”
.
Lookit! Drunks and dopers can create research papers and pie charts! Who could've ever guessed?
 
"A team of German investigators compared the safety and efficacy of a proprietary cannabis extract (VER-01) containing 2.5 mg of THC and standardized percentages of CBD and CBG (cannabigerol) to commercially available opioids in a cohort of 392 older adults with intractable lower back pain. Study participants were randomly designated to use either opioids or cannabis extracts for six months.
.
Those who consumed
opioids were far more likely to experience constipation as compared to those taking cannabis extracts. Participants who consumed extracts did not experience withdrawal symptoms following the study’s conclusion."
.
 
"A team of German investigators compared the safety and efficacy of a proprietary cannabis extract (VER-01) containing 2.5 mg of THC and standardized percentages of CBD and CBG (cannabigerol) to commercially available opioids in a cohort of 392 older adults with intractable lower back pain. Study participants were randomly designated to use either opioids or cannabis extracts for six months.
.
Those who consumed
opioids were far more likely to experience constipation as compared to those taking cannabis extracts. Participants who consumed extracts did not experience withdrawal symptoms following the study’s conclusion."
.
We have it from top officials in the Biden administration that there is nothing wrong with smack and smoke.

1759642631101.webp


1759642696344.webp


1759642727086.webp


1759642749251.webp


1759642772386.webp

1759642839904.webp
 
"Cannabis formulations containing THC and CBN (cannabinol) are associated with improved sleep quality, according to the findings of a meta-analysis published in the journal Sleep Medicine Reviews.
.
Brazilian researchers reviewed data from six randomized controlled trials involving 1,077
participants.
.
“Our findings indicate that only treatments incorporating THC and/or CBN were associated with a significant improvement in subjective sleep assessments compared with placebo, whereas interventions with CBD alone did not demonstrate a statistically significant effect,” researchers reported. “These results support the hypothesis that different cannabinoids may exert distinct roles in modulating sleep-related therapeutic benefits.”
.

One in six U.S. adults say that they use cannabis as a sleep aid, according to survey data compiled earlier this year by Harris Polling. Data published in the journal Complementary Therapies in Medicine reports that the enactment of adult-use marijuana legalization laws is associated with significant reductions in the sales of over-the-counter sleep aids." (i.e. antihistamines)
dizzy-smiley-emoticon-1[1].gif
.
 
Last edited:
"Cannabinoids reduce dementia-induced agitation in older patients and “offer a promising therapeutic option for managing behavioral and psychological symptoms of dementia,” according to the findings of a systematic review published in the Journal of Psychopharmacology.
.
A team of Italian investigators reviewed data from ten
published studies involving 278 participants. Study subjects were at least 60 years old and suffered from either Alzheimers, vascular, or mixed dementia."
.
 
Werbung:
"Cannabis use is associated with sustained reductions in analgesia* and improvements in glycemic* control in patients suffering from diabetic neuropathy*, according to longitudinal data published in the journal Biomedicines.
.
Israeli researchers assessed the adjunctive use of inhaled cannabis in a cohort of 50
patients suffering from treatment-resistant diabetic neuropathy. Study participants inhaled standardized, medical-grade cannabis flower (20 percent THC | 1 percent CBD) for five years.
.

Patients reported significant decreases in their pain scores, as well reductions in their use of opioids and other prescription analgesics*, over the span of the study. Specifically, participants decreased their morphine-equivalent doses by more than 90 percent, their gabapentin* doses by 97 percent, duloxetine* by 93 percent, and pregabalin* by 79 percent without developing rebound pain. Patientspain severity decreased from a mean of nine to two on a numerical rating scale."
.
* Helping the least-educated wherever you can.
.
 
Back
Top